Search Results

You are looking at 101 - 110 of 377 items for :

  • "high-grade" x
  • Refine by access: All content x
Clear All
Antoinette S Perry
Search for other papers by Antoinette S Perry in
Google Scholar
PubMed
Close
,
Ruth Foley
Search for other papers by Ruth Foley in
Google Scholar
PubMed
Close
,
Karen Woodson
Search for other papers by Karen Woodson in
Google Scholar
PubMed
Close
, and
Mark Lawler
Search for other papers by Mark Lawler in
Google Scholar
PubMed
Close

determining relevant early detection biomarkers, it is important to understand the molecular mechanisms implicated in CaP initiation. Therefore, investigations have focused on premalignant lesions as well as early-stage disease. High-grade prostatic

Free access
Helen Gharwan National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Helen Gharwan in
Google Scholar
PubMed
Close
,
Kristen P Bunch National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA
National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Kristen P Bunch in
Google Scholar
PubMed
Close
, and
Christina M Annunziata National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Christina M Annunziata in
Google Scholar
PubMed
Close

). Serous cancers The epithelial cells covering the ovaries have historically been considered the site of origin of all ovarian cancers but recent evidence suggests that high-grade serous carcinoma (HGSC) originates from FT epithelium or the tuboperitoneal

Free access
Marianne E Pavel Medical Department, Division of Hepatology and Gastroenterology including Metabolic Diseases, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany

Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Close
and
Christine Sers Institute of Pathology, Charité University Medicine, Berlin, Germany

Search for other papers by Christine Sers in
Google Scholar
PubMed
Close

dedifferentiate to high-grade neoplasms requiring cytotoxic chemotherapy ( Paul et al. 2016 ); in contrast, in tumors responding to therapies (either chemotherapy or targeted drugs) the grade/ proliferative activity may decrease ( Yao et al. 2008 b ) or growth

Free access
A Bardin
Search for other papers by A Bardin in
Google Scholar
PubMed
Close
,
N Boulle
Search for other papers by N Boulle in
Google Scholar
PubMed
Close
,
G Lazennec
Search for other papers by G Lazennec in
Google Scholar
PubMed
Close
,
F Vignon
Search for other papers by F Vignon in
Google Scholar
PubMed
Close
, and
P Pujol
Search for other papers by P Pujol in
Google Scholar
PubMed
Close

antibody revealed the differential expression of ERβ in tissue sections from 132 patients with prostate cancer. Moreover, these authors showed partial loss of ERβ in high-grade prostatic intraepithelial neoplasia (HGPIN) (Table 3 ). Once more, the change

Free access
Maria Chiara Zatelli Department of Medical Sciences, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Close
,
Erika Maria Grossrubatscher Endocrine Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Search for other papers by Erika Maria Grossrubatscher in
Google Scholar
PubMed
Close
,
Elia Guadagno Department of Advanced Biomedical Sciences, Pathology Section, University of Naples Federico II, Naples, Italy

Search for other papers by Elia Guadagno in
Google Scholar
PubMed
Close
,
Concetta Sciammarella IOS & COLEMAN Srl, Naples, Italy

Search for other papers by Concetta Sciammarella in
Google Scholar
PubMed
Close
,
Antongiulio Faggiano Thyroid and Parathyroid Surgery Unit, Istituto Nazionale per lo Studio e la Cura Dei Tumori ‘Fondazione G. Pascale’ – IRCCS, Naples, Italy

Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Close
, and
Annamaria Colao IOS & COLEMAN Srl, Naples, Italy

Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Close

-regulated Prostate Predictive of high grade tumor Mihelich et al . (2015) miR-24 miR-26b miR-30c miR 93 miR-100 miR-103 miR-106a miR-107 miR

Free access
Thomas J Giordano Divisions of Anatomic Pathology and Molecular & Genomic Pathology, Departments of Pathology and Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA

Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
Close

-based prognostic grading scheme, classifying ACCs as either low or high grade ( Weiss et al . 1989 ). This simple two-class scheme was confirmed by studies of the cancer transcriptome using independent patient cohorts ( de Reynies et al . 2009 , Giordano et al

Free access
Kiranjit K Dhillon Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Search for other papers by Kiranjit K Dhillon in
Google Scholar
PubMed
Close
,
Ilirjana Bajrami The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK

Search for other papers by Ilirjana Bajrami in
Google Scholar
PubMed
Close
,
Toshiyasu Taniguchi Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Search for other papers by Toshiyasu Taniguchi in
Google Scholar
PubMed
Close
, and
Christopher J Lord The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK

Search for other papers by Christopher J Lord in
Google Scholar
PubMed
Close

thought to display the BRCAness phenotype, namely high-grade serous ovarian cancer (HGSOvCa) and triple-negative breast cancers (described earlier). In patients with HGSOvCa both BRCA1/2 gene mutant and non-mutant patients demonstrated a number of

Free access
Fazlul H Sarkar Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 740 HWCRC, 4100 John R Street, Detroit, Michigan 48201, USA

Search for other papers by Fazlul H Sarkar in
Google Scholar
PubMed
Close
,
Yiwei Li Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 740 HWCRC, 4100 John R Street, Detroit, Michigan 48201, USA

Search for other papers by Yiwei Li in
Google Scholar
PubMed
Close
,
Zhiwei Wang Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 740 HWCRC, 4100 John R Street, Detroit, Michigan 48201, USA

Search for other papers by Zhiwei Wang in
Google Scholar
PubMed
Close
, and
Dejuan Kong Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 740 HWCRC, 4100 John R Street, Detroit, Michigan 48201, USA

Search for other papers by Dejuan Kong in
Google Scholar
PubMed
Close

–10 was higher in the finasteride group than in the placebo group, suggesting that the benefit of reducing the risk of PCa by finasteride must be weighed against the increased risk of development of high-grade PCa ( Thompson et al . 2003 ). Recently

Free access
Kaylee B Punter Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada

Search for other papers by Kaylee B Punter in
Google Scholar
PubMed
Close
,
Charles Chu Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada

Search for other papers by Charles Chu in
Google Scholar
PubMed
Close
, and
Edmond Y W Chan Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada

Search for other papers by Edmond Y W Chan in
Google Scholar
PubMed
Close

with alterations in OXPHOS or mitochondrial metabolism genes ( Lahiguera et al. 2020 ). It was further dissected using high-grade serous ovarian cancer cells that the loss of homologous recombination shifted the burden towards PARP-dependent DNA

Free access
Juan Díaz-Martín Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain
Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by Juan Díaz-Martín in
Google Scholar
PubMed
Close
,
María Ángeles López-García Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by María Ángeles López-García in
Google Scholar
PubMed
Close
,
Laura Romero-Pérez Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by Laura Romero-Pérez in
Google Scholar
PubMed
Close
,
María Reina Atienza-Amores Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by María Reina Atienza-Amores in
Google Scholar
PubMed
Close
,
María Luisa Pecero Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by María Luisa Pecero in
Google Scholar
PubMed
Close
,
María Ángeles Castilla Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by María Ángeles Castilla in
Google Scholar
PubMed
Close
,
Michele Biscuola Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by Michele Biscuola in
Google Scholar
PubMed
Close
,
Almudena Santón Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by Almudena Santón in
Google Scholar
PubMed
Close
, and
José Palacios Department of Pathology, Red Temática de Investigación Cooperativa en Cáncer (RETICC, Department of Pathology, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Avenida Manuel Siurot S/N, 41013 Seville, Spain

Search for other papers by José Palacios in
Google Scholar
PubMed
Close

TAZ has been found in high-grade breast carcinomas, and it has been shown to have an influence on patient prognosis ( Bartucci et al . 2014 ). However, the analysis of TAZ protein expression across different breast cancer phenotypes has not, to our

Free access